Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1B |
| 2 |
Tesla
TSLA
|
+$697M |
| 3 |
Microsoft
MSFT
|
+$447M |
| 4 |
Accenture
ACN
|
+$439M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$421M |
Top Sells
| 1 |
CRH
CRH
|
+$2.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.01B |
| 3 |
Texas Instruments
TXN
|
+$1.97B |
| 4 |
Starbucks
SBUX
|
+$1.61B |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$1.07B |
Sector Composition
| 1 | Technology | 32.41% |
| 2 | Financials | 11.84% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Healthcare | 9.02% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Procore
PCOR
$10.5B
| $4.26M | ﹤0.01% |
69,012
+22,734
| +49% | +$1.4M |
|
1627
AZZ Inc
AZZ
$3.52B
| $4.25M | ﹤0.01% |
51,458
+40,938
| +389% | +$3.38M |
|
1628
Kennametal
KMT
$1.58B
| $4.24M | ﹤0.01% |
163,670
+79,992
| +96% | +$2.07M |
|
1629
Invesco NASDAQ 100 ETF
QQQM
$60.6B
| $4.24M | ﹤0.01% |
21,113
+20,653
| +4,490% | +$4.15M |
|
1630
Marqeta
MQ
$2.61B
| $4.24M | ﹤0.01% |
861,414
+597,539
| +226% | +$2.94M |
|
1631
Kilroy Realty
KRC
$5.11B
| $4.23M | ﹤0.01% |
109,263
-30,904
| -22% | -$1.2M |
|
1632
Ambac
AMBC
$413M
| $4.22M | ﹤0.01% |
376,102
+88,863
| +31% | +$996K |
|
|
ITWO
1633
ProShares Russell 2000 High Income ETF
ITWO
$62.8M
| $4.21M | ﹤0.01% |
+100,000
| New | +$4.21M |
|
1634
Oxford Industries
OXM
$701M
| $4.21M | ﹤0.01% |
48,484
+20,620
| +74% | +$1.79M |
|
1635
Valmont Industries
VMI
$7.37B
| $4.2M | ﹤0.01% |
14,488
+6,927
| +92% | +$2.01M |
|
1636
Vishay Intertechnology
VSH
$2.07B
| $4.2M | ﹤0.01% |
221,932
+40,763
| +22% | +$771K |
|
1637
Ryder
R
$7.65B
| $4.2M | ﹤0.01% |
28,780
+3,344
| +13% | +$488K |
|
1638
BCE
BCE
$22.5B
| $4.19M | ﹤0.01% |
120,462
+52,966
| +78% | +$1.84M |
|
1639
Team
TISI
$81.8M
| $4.19M | ﹤0.01% |
274,706
+18,733
| +7% | +$286K |
|
1640
First Merchants
FRME
$2.31B
| $4.18M | ﹤0.01% |
112,290
+53,033
| +89% | +$1.97M |
|
1641
Customers Bancorp
CUBI
$2.32B
| $4.18M | ﹤0.01% |
89,879
+28,683
| +47% | +$1.33M |
|
1642
Surgery Partners
SGRY
$2.8B
| $4.16M | ﹤0.01% |
129,133
-211,901
| -62% | -$6.83M |
|
1643
Cullinan Oncology
CGEM
$386M
| $4.16M | ﹤0.01% |
248,614
+51,300
| +26% | +$859K |
|
1644
Standex International
SXI
$2.47B
| $4.16M | ﹤0.01% |
22,752
+10,159
| +81% | +$1.86M |
|
1645
British American Tobacco
BTI
$123B
| $4.14M | ﹤0.01% |
113,091
-1,509,637
| -93% | -$55.2M |
|
1646
Kinross Gold
KGC
$28.4B
| $4.13M | ﹤0.01% |
441,413
-357,224
| -45% | -$3.34M |
|
1647
Fluence Energy
FLNC
$917M
| $4.13M | ﹤0.01% |
181,766
+135,957
| +297% | +$3.09M |
|
|
VGR
1648
DELISTED
Vector Group Ltd.
VGR
| $4.13M | ﹤0.01% |
276,687
+222,159
| +407% | +$3.31M |
|
1649
Vir Biotechnology
VIR
$695M
| $4.12M | ﹤0.01% |
550,186
+7,287
| +1% | +$54.6K |
|
1650
UFP Technologies
UFPT
$1.54B
| $4.1M | ﹤0.01% |
12,937
+10,300
| +391% | +$3.26M |
|